STMN2 and frontotemporal dementia: To model Stmn2 loss of function in vivo and assess its relevance in FTD, we first generated a novel knockin CRISPRi mouse model using a system that previously demonstrated effective silencing of target genes in vitro (Gilbert et al., 2014).